Physician profile
Matthew E Emanuel
NPI 1487986170
$47,384.62
in general payments reported to CMS, 2019-2025
20 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $17K · 2021: $4,262 · 2022: $512 · 2023: $585 · 2024: $867 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,455.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $43,767.91 | 2019-2021 | |
| Abbvie INC. | $1,542.02 | 2022-2025 | |
| Glaukos Corporation | $398.38 | 2023-2025 | Idose, Idosetr |
| Alcon Vision LLC | $339.33 | 2019-2025 | Rocklatan |
| Allergan, INC. | $247.74 | 2019-2021 | |
| Biotissue Holdings INC. | $159.96 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $159.48 | 2022-2024 | Vyzulta, Xiidra |
| Amgen INC. | $146.35 | 2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $119.57 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $107.25 | 2020-2025 | Tecnis Iol |
| Ivantis, INC | $99.99 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $68.23 | 2019-2021 | |
| Sight Sciences, INC. | $64.29 | 2023-2025 | Omni Surgical System |
| Thea Pharma INC. | $42.34 | 2025 | Iyuzeh |
| Rxsight INC | $32.48 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $24.69 | 2019 | |
| Nova Eye, INC. | $24.01 | 2023 | |
| Carl Zeiss Meditec USA, INC. | $20.74 | 2022 | |
| Oyster Point Pharma, INC. | $19.86 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Emanuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.